| CAS: | 35604-67-2 | |||||||||||
| 分子式: | C13H20ClNO3 | |||||||||||
| 分子量: | 273.76 | |||||||||||
| 熔点: | 178-180 °C | |||||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||
| 782446 | MACKLIN | 2-((2-乙氧基苯氧基)甲基)吗啉盐酸盐 | 98% | 563元/100mg; 937元/250mg; 2056元/1g; | 展开 | ||||||||||||||||||||||||||||||||||||||||
储存:室温, 密封, 惰性气体 | |||||||||||||||||||||||||||||||||||||||||||||
| SML3133 | Sigma-Aldrich | Viloxazine hydrochloride | ≥95% (HPLC) | 780.67元/10 MG; 3157.38元/50 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||
产品说明 生化/生理作用 Viloxazine (ICI 58,834) is an orally active serotonin norepinephrine modulating agent (SNMA) originally reported as a norepinephrine reuptake inhibitor (NRI) with antidepressant (ED10 from 0.3-1 mg/kg p.o. against reserpine-induced hypothermia in mice), while exhibiting less sedative efficacy (locomotor activity reduction ED10 from 3-10 mg/kg p.o. in mice) and no monoamine oxidase inhibitory potency. Viloxazine shows 5-HT2B antagonist and 5-HT2C agonist activity in vitro and increases extracellular 5-HT levels in the prefrontal cortex (PFC) in vivo, a brain area implicated in Attention deficit hyperactivity disorder (ADHD). 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||